Search PubMed⌕ Search

Biomedical subjects

M Benjamin

Publications and source records attributed to M Benjamin.

102 records · Page 6Linked to original sources

The adenohypophysis of the flounder, Pleuronectes flesus, and the minnow, Phoxinus phoxinus.

The pituitary gland of the flounder, Pleuronectes flesus, showed several unusual cytological features. Between the RPD and the PPD was a zone of cells that stained purple with Alcian blue--PAS--orange G. Many of these cells were apparently degenerating. In the PPD the strands and coils of presumptive STH cells showed a tremendous variation in both size and staining properties. In the PI there were two cell types, the PAS-positive one bordering the neurohypophysis. Around the periphery of the PI was a zone of chromophobic cells, and throughout the PI were numerous intracellular and extracellular acidophil spheres. No well defined ACTH cells were found in the RPD of the minnow (Phoxinus phoxinus). The Alcian blue--PAS--orange G technique distinguishes between blue TSH cells and purple GTH cells in the RPD and PPD. GTH cells from animals collected in the winter were vacuolated. The PI contained two cell types whose staining reactions and ultrastructure were extremely variable. Intra- and extra-cellular acidophil spheres were present.

Adrenocorticotropic Hormone↗

Cardiac anoxia tolerance of carbon monoxide-poisoned, hypoxia-exposed and normal rats.

Under nitrogen anoxia heart rate (HR) persists at a high level for 1 min longer in rats exposed chronically to carbon monoxide and hypoxia than in unexposed control rats. Although declining sharply, HR of exposed animals continues higher than HR of controls during min 1-4 of anoxia. However, during min 5 and 6 of anoxia HR of CO-poisoned rats becomes similar to that of controls, while HR of hypoxia-exposed rats remains above control HR for 3 min longer. The data are discussed in light of cardiovascular changes induced by CO and hypobaric hypoxia.

Animals↗

Measurement and management of hyperlipidemia for the primary prevention of coronary heart disease.

BACKGROUND: As part of the National Cholesterol Education Program (NCEP) two expert panel reports (1988, 1993) recommend serum cholesterol measurements in all adults aged 20 years and older and cholesterol-lowering treatment for those with abnormal levels. METHODS: All major drug intervention trials for primary prevention of coronary heart disease were reviewed. Similarly, selected studies on risks of dyslipidemia and benefit of therapy for the elderly and for women without coronary heart disease were analyzed. These studies were evaluated to test the soundness of the NCEP panel's recommendations. RESULTS AND CONCLUSIONS: Five major randomized drug intervention trials for primary prevention of coronary heart disease showed that cholestyramine, gemfibrozil, clofibrate, and pravastatin can reduce the rate of nonfatal myocardial infarctions in middle-aged men. All-cause and ischemic heart disease mortality were increased by clofibrate and unaffected by the other three drugs. Extrapolation of these findings to women and older and younger men is unwarranted because there is no evidence that either diet or drugs provide primary protection from coronary heart disease in these groups. It is uncertain whether dyslipidemia is a risk factor for coronary heart disease in the elderly. The annual cost of drugs for full implementation of the panel's recommendations ranges from $6 billion to $11.5 billion and an additional $13 billion will be required for initial screening, classifying, and monitoring serum cholesterol levels. Potential adverse consequences of a national program include possible risks from low cholesterol levels, drug side-effects, and disease labeling.

Adult↗